Freightos Ltd

CRGO· Nasdaq

Since Oct 3, 2025

Transactions: 19
Purchases: 0
Sales: 19
Purchase value: $0.00
Sale value: $73.86K

Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.

Arroyo IanChief Strategy Officer

Filed Jul 20, 2026Period of report Jul 16, 20260001104659-26-085104

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
SaleJul 16, 2026	Ordinary Shares^F1^F2	760	$1.27	$965.20	4,730	Direct
SaleJul 16, 2026	Ordinary Shares^F1^F3	1,000	$1.27	$1.27K	18,513	Direct

Filing footnotes · 10

F1The transaction reported in this row consists of a sale on behalf of the Reporting Person to cover tax liability for vesting of restricted share units ("RSUs") that had been granted by the Issuer to the Reporting Person.
F10The ordinary shares reported in this row consist of shares underlying RSUs granted to the Reporting Person that were granted to, and began vesting for, the Reporting Person on April 1, 2026 and that vest and settle for underlying ordinary shares based on the following schedule: 33% of the subject RSUs will vest upon the one-year anniversary of the grant date (April 1, 2027), and the remainder of the RSUs will vest in eight equal installments at the conclusion of each of the following eight quarters (8.25% per quarter), such that the RSUs will be fully vested by the three-year anniversary of the vesting commencement date (April 1, 2029).
F2The ordinary shares reported in this row consist of the remaining shares (following sales to cover tax liability) underlying 7,000 RSUs originally granted by the Issuer to the Reporting Person that began vesting on October 15, 2025. Such RSUs have vested in full as of July 15, 2026 (reduced by any RSUs for which underlying shares have been sold to cover tax liability). In addition to the 760 shares sold as reported in this row and the 756 shares from this grant sold on April 16, 2026 as reported in the Form 4 filed on April 20, 2026, an additional 754 shares were sold to cover tax liability previously (before the Reporting Person was subject to Section 16), such that only 4,730 ordinary shares are currently held by the Reporting Person from the 7,000 RSUs originally granted.
F3The ordinary shares reported in this row consist of the remaining shares (following sales to cover tax liability) underlying 21,500 RSUs originally granted by the Issuer to the Reporting Person that began vesting on October 15, 2025. Such RSUs vest equally on a quarterly basis over seven calendar quarters (approximately 14.286% per quarter), such that all such RSUs (reduced by any RSUs for which underlying shares have been sold to cover tax liability) will be fully vested by July 15, 2027. In addition to the 1,000 shares sold as reported in this row and the 995 shares from this grant sold on April 16, 2026 as reported in the Form 4 filed on April 20, 2026, an additional 992 shares were sold to cover tax liability previously (before the Reporting Person was subject to Section 16), such that only 18,513 RSUs and/or underlying ordinary shares are currently held by the Reporting Person from the 21,500 RSUs originally granted.

Open on SEC EDGAR

Alventosa Abril EnricChief Technology Officer

Filed Jul 20, 2026Period of report Jul 16, 20260001104659-26-085064

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
SaleJul 16, 2026	Ordinary Shares^F1^F2	1,175	$1.28	$1.50K	1,394

Indave Sesma AndreaVP, Human Resources

Filed Jul 20, 2026Period of report Jul 16, 20260001104659-26-085056

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
SaleJul 16, 2026	Ordinary Shares^F1^F2	199	$1.27	$252.73	3,602

Pinillos Manrique de Lara PabloDirector · CEO and CFO

Filed Jul 7, 2026Period of report Jul 2, 20260001104659-26-081274

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
SaleJul 2, 2026	Ordinary Shares^F1^F2	1,524	$1.31	$2.00K	32,661

Arroyo IanChief Strategy Officer

Filed Jul 7, 2026Period of report Jul 2, 20260001104659-26-081273

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
SaleJul 2, 2026	Ordinary Shares^F1^F2	3,901	$1.31	$5.11K	32,099

Arroyo IanChief Strategy Officer

Filed Jun 16, 2026Period of report Jun 15, 20260001104659-26-074571

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
SaleJun 15, 2026	Ordinary Shares^F1	1,217	$1.59	$1.94K	23,924	Direct

Alventosa Abril EnricChief Technology Officer

Filed Jun 1, 2026Period of report May 28, 20260001104659-26-068901

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
SaleMay 28, 2026	Ordinary Shares^F1	2,904	$2.05	$5.95K	26,746	Direct

Indave Sesma AndreaVP, Human Resources

Filed Apr 20, 2026Period of report Apr 16, 20260001104659-26-045484

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
SaleApr 16, 2026	Ordinary Shares^F1^F2	193	$1.85	$357.05	5,657

Alventosa Abril EnricChief Technology Officer

Filed Apr 20, 2026Period of report Apr 16, 20260001104659-26-045483

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
SaleApr 16, 2026	Ordinary Shares^F1^F2	1,170	$1.85	$2.16K	29,650

Arroyo IanChief Strategy Officer

Filed Apr 20, 2026Period of report Apr 16, 20260001104659-26-045480

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
SaleApr 16, 2026	Ordinary Shares^F1^F2	756	$1.85	$1.40K	6,244

Pinillos Manrique de Lara PabloDirector · CEO and CFO

Filed Apr 7, 2026Period of report Apr 6, 20260001104659-26-040367

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
SaleApr 6, 2026	Ordinary Shares^F1^F2	5,815	$1.69	$9.83K	34,185

Pinillos Manrique de Lara PabloDirector · CEO and CFO

Filed Mar 31, 2026Period of report Mar 31, 20260001104659-26-037983

Transaction	Security	Shares	Price	ValueValue (shares × price)	Held after	Ownership
SaleMar 31, 2026	Ordinary Shares^F1	17,898	$1.57	$28.10K	24,102	Direct

P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.

Filing footnotes · 7

F1The transaction reported in this row consists of a sale on behalf of the Reporting Person to cover tax liability for vesting of restricted share units ("RSUs") that had been granted by the Issuer to the Reporting Person.
F2The ordinary shares reported in this row consist of the remaining shares (following sales to cover tax liability) underlying 30,820 RSUs originally granted by the Issuer to the Reporting Person that began vesting (and settling for underlying ordinary shares) on July 15, 2023. Such RSUs (reduced by any RSUs for which underlying shares have been sold to cover tax liability) are now fully vested and have been settled for underlying ordinary shares. In addition to the 1,175 shares sold as reported in this row, the 2,904 shares from this grant sold on May 28, 2026 as reported in the Form 4 filed on June 1, 2026, and the 1,170 shares from this grant sold on April 16, 2026 as reported in the Form 4 filed on April 20, 2026, an additional 24,177 shares were sold (in certain cases, to cover tax liability) previously (before the Reporting Person was subject to Section 16), such that only 1,394 ordinary shares are currently held by the Reporting Person from the 30,820 RSUs originally granted.
F3The ordinary shares reported in this row consist of the remaining shares (following sales to cover tax liability) underlying 35,480 RSUs originally granted by the Issuer to the Reporting Person that began vesting (and settling for underlying ordinary shares) on July 15, 2024. Such RSUs vest in accordance with the following schedule: 33.33% of those RSUs vested upon the one-year anniversary of the vesting commencement date and the remaining RSUs vest equally on a quarterly basis over the following ten quarters (6.66% per quarter) such that all such RSUs (reduced by any RSUs for which underlying shares are sold to cover tax liability) will be vested by December 31, 2027.
F4In addition to the 1,353 shares sold as reported in this row, and the 1,347 shares from this grant sold on April 16, 2026 as reported in the Form 4 filed on April 20, 2026, an additional 16,006 shares were sold (in certain cases, to cover tax liability) previously (before the Reporting Person was subject to Section 16), such that only 16,774 RSUs and/or underlying ordinary shares are currently held by the Reporting Person from the 35,480 RSUs originally granted.
F5There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.
F6The ordinary shares reported in this row consist of shares underlying 25,000 RSUs originally granted by the Issuer to the Reporting Person that began vesting (and settling for underlying ordinary shares) on March 13, 2025 and that vest (and settle for underlying ordinary shares) in their entirety on December 31, 2026.
F7The stock options reported in this row granted by the Issuer to the Reporting Person began vesting (and becoming exercisable for underlying ordinary shares) on October 1, 2022, in accordance with the following schedule: 25% of the options vested upon the one-year anniversary of the vesting commencement date and the remaining options vest equally on a quarterly basis over the following twelve quarters (6.125% per quarter) such that all such options will be vested by the four-year anniversary of the vesting commencement date.

Filing footnotes · 6

F1The transaction reported in this row consists of a sale on behalf of the Reporting Person to cover tax liability for vesting of restricted share units ("RSUs") that had been granted by the Issuer to the Reporting Person.
F2The ordinary shares reported in this row consist of the remaining shares (following sales to cover tax liability) underlying 5,850 RSUs originally granted by the Issuer to the Reporting Person that began vesting (and settling for underlying ordinary shares) on July 15, 2023. Such RSUs (reduced by any RSUs for which underlying shares have been sold to cover tax liability) are now fully vested and have been settled for underlying ordinary shares. In addition to the 199 shares sold as reported in this row and the 193 shares from this grant sold on April 16, 2026 as reported in the Form 4 filed on April 20, 2026, an additional 1,856 shares were sold to cover tax liability previously (before the Reporting Person was subject to Section 16), such that only 3,602 ordinary shares are currently held by the Reporting Person from the 5,850 RSUs originally granted.
F3The ordinary shares reported in this row consist of the remaining shares (following sales to cover tax liability) underlying 19,830 RSUs originally granted by the Issuer to the Reporting Person that began vesting (and settling for underlying ordinary shares) on July 15, 2024. Such RSUs vest in accordance with the following schedule: 33.33% of those RSUs vested upon the one-year anniversary of the vesting commencement date and the remaining RSUs vest equally on a quarterly basis over the following eight quarters (8.3325% per quarter) such that all such RSUs (reduced by any RSUs for which underlying shares are sold to cover tax liability) will be fully vested by July 15, 2027.
F4In addition to the 672 shares sold as reported in this row and the 653 shares from this grant sold on April 16, 2026 as reported in the Form 4 filed on April 20, 2026, an additional 3,862 shares were sold to cover tax liability previously (before the Reporting Person was subject to Section 16), such that only 14,643 RSUs and/or underlying ordinary shares are currently held by the Reporting Person from the 19,830 RSUs originally granted.
F5The ordinary shares reported in this row consist of the remaining shares (following sales to cover tax liability) underlying 28,000 RSUs originally granted by the Issuer to the Reporting Person that began vesting (and settling for underlying ordinary shares) on July 15, 2025. Such RSUs vest in accordance with the following schedule: 33.33% of those RSUs vested upon the one-year anniversary of the vesting commencement date (July 15, 2026), and the remaining RSUs vest equally on a quarterly basis over the following eight quarters (8.3325% per quarter) such that all such RSUs (reduced by any RSUs for which underlying shares are sold to cover tax liability) will be fully vested by July 15, 2028.
F6There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.

Filing footnotes · 6

F1The transaction reported in this row consists of a sale on behalf of the Reporting Person to cover tax liability for vesting of restricted share units ("RSUs") that had been granted by the Issuer to the Reporting Person.
F2The ordinary shares reported in this row consist of the remaining shares (following sales to cover tax liability) underlying 40,000 RSUs originally granted by the Issuer to the Reporting Person that began vesting on April 1, 2025. 33.33% of such RSUs vested on April 1, 2026 (the one-year anniversary of the vesting commencement date), and the remaining RSUs vest equally on a quarterly basis over the following eight quarters (8.3325% per quarter), such that all such RSUs (reduced by any RSUs for which underlying shares have been sold to cover tax liability) will be fully vested by the three-year anniversary of the vesting commencement date (April 1, 2028).
F3There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.
F4The ordinary shares reported in this row consist of shares underlying RSUs that were granted by the Issuer to, and began vesting for, the Reporting Person on April 1, 2026 and that vest and settle for underlying ordinary shares based on the following schedule: 33.33% of the subject RSUs will vest upon the one-year anniversary of the grant date (April 1, 2027), and the remainder of the RSUs will vest in eight equal installments at the conclusion of each of the following eight quarters (8.33% per quarter), such that the RSUs will be fully vested by the three-year anniversary of the vesting commencement date (April 1, 2029).
F5The ordinary shares reported in this row consist of shares underlying RSUs granted by the Issuer to the Reporting Person that began vesting for the Reporting Person on April 1, 2025 and that vest and settle for underlying ordinary shares, in their entirety, on December 31, 2028.
F6The ordinary shares reported in this row consist of shares underlying RSUs granted by the Issuer to the Reporting Person that began vesting for the Reporting Person on April 1, 2025 and that vest and settle for underlying ordinary shares, in their entirety, on December 31, 2027.

Filing footnotes · 10

F1The transaction reported in this row consists of the sale of ordinary shares on behalf of the Reporting Person to satisfy applicable withholding tax obligations arising from the vesting of restricted share units ("RSUs") previously granted by the Issuer to the Reporting Person.
F10The ordinary shares reported in this row consist of shares underlying RSUs granted to the Reporting Person that were granted to, and began vesting for, the Reporting Person on April 1, 2026 and that vest and settle for underlying ordinary shares based on the following schedule: 33% of the subject RSUs will vest upon the one-year anniversary of the grant date (April 1, 2027), and the remainder of the RSUs will vest in eight equal installments at the conclusion of each of the following eight quarters (8.25% per quarter), such that the RSUs will be fully vested by the three-year anniversary of the vesting commencement date (April 1, 2029).
F2The ordinary shares reported in this row consist of the remaining shares (following sales to cover tax liability) underlying 36,000 RSUs originally granted to the Reporting Person by the Issuer that began vesting on July 1, 2025. 33.33% of such RSUs vested on July 1, 2026 (the one-year anniversary of the vesting commencement date), and the remaining RSUs vest equally on a quarterly basis over the following eight quarters (8.3325% per quarter), such that all such RSUs (reduced by any RSUs for which underlying shares have been sold to cover tax liability) will be fully vested by the three-year anniversary of the vesting commencement date (July 1, 2028).
F3There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.
F4The ordinary shares reported in this row consist of shares underlying restricted share units ("RSUs") that were granted to the Reporting Person by the Issuer that began vesting on October 15, 2025. The 7,000 RSUs originally granted vest (and settle for underlying ordinary shares) on an equal, quarterly basis over three calendar quarters (33.33% per quarter) such that all such 7,000 RSUs (reduced by any RSUs for which underlying shares have been sold to cover tax liability) will be vested by July 15, 2026.
F5The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person by the Issuer that began vesting on October 15, 2025. The 21,500 RSUs originally granted vest (and settle for underlying ordinary shares) on an equal, quarterly basis over seven calendar quarters (approximately 14.286% per quarter) such that all such 21,500 RSUs (reduced by any RSUs for which underlying shares have been sold to cover tax liability) will be vested by July 15, 2027.
F6The ordinary shares reported in this row consist of shares underlying RSUs granted to the Reporting Person by the Issuer that began vesting on March 13, 2025 and that vest (and settle for underlying ordinary shares) in their entirety on December 31, 2027.
F7The ordinary shares reported in this row consist of shares underlying RSUs granted to the Reporting Person by the Issuer that began vesting on March 13, 2025 and that vest (and settle for underlying ordinary shares) in their entirety on July 15, 2026.
F8The ordinary shares reported in this row consist of shares underlying RSUs granted to the Reporting Person by the Issuer that began vesting on October 15, 2025 and that vest (and settle for underlying ordinary shares) in their entirety on December 30, 2026.
F9The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person by the Issuer that began vesting on October 15, 2025 and that vest (and settle for underlying ordinary shares) in their entirety on December 30, 2027.

Filing footnotes · 10

F1The transaction reported in this row consists of the sale of ordinary shares on behalf of the Reporting Person to satisfy applicable withholding tax obligations arising from the grant of ordinary shares to the Reporting Person upon his achievement of performance criteria under performance share units ("PSUs") previously granted by the Issuer to the Reporting Person.
F10The ordinary shares reported in this row consist of shares underlying RSUs granted to the Reporting Person that were granted to, and began vesting for, the Reporting Person on April 1, 2026 and that vest and settle for underlying ordinary shares based on the following schedule: 33% of the subject RSUs will vest upon the one-year anniversary of the grant date (April 1, 2027), and the remainder of the RSUs will vest in eight equal installments at the conclusion of each of the following eight quarters (8.25% per quarter), such that the RSUs will be fully vested by the three-year anniversary of the vesting commencement date (April 1, 2029).
F2There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.
F3The ordinary shares reported in this row consist of shares underlying restricted share units ("RSUs") that were granted to the Reporting Person by the Issuer that began vesting on October 15, 2025. The 7,000 RSUs originally granted vest (and settle for underlying ordinary shares) on an equal, quarterly basis over three calendar quarters (33.33% per quarter) such that all such 7,000 RSUs (reduced by any RSUs for which underlying shares are sold to cover tax liability) will be vested by July 15, 2026.
F4The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person by the Issuer that began vesting on October 15, 2025. The 21,500 RSUs originally granted vest (and settle for underlying ordinary shares) on an equal, quarterly basis over seven calendar quarters (approximately 14.286% per quarter) such that all such 21,500 RSUs (reduced by any RSUs for which underlying shares are sold to cover tax liability) will be vested by July 15, 2027.
F5The ordinary shares reported in this row consist of shares underlying RSUs granted to the Reporting Person by the Issuer that began vesting on March 13, 2025 and that vest (and settle for underlying ordinary shares) in their entirety on December 31, 2027.
F6The ordinary shares reported in this row consist of shares underlying RSUs granted to the Reporting Person by the Issuer that began vesting on March 13, 2025 and that vest (and settle for underlying ordinary shares) in their entirety on July 15, 2026.
F7The ordinary shares reported in this row consist of shares underlying RSUs granted to the Reporting Person by the Issuer that began vesting on July 1, 2025 and that vest (and settle for underlying ordinary shares) in accordance with the following schedule: 33.33% of the RSUs vest upon the one-year anniversary of the vesting commencement date, and the remaining RSUs vest equally on a quarterly basis over the following eight quarters (8.3325% per quarter) such that all such RSUs will be vested by the three-year anniversary of the vesting commencement date.
F8The ordinary shares reported in this row consist of shares underlying RSUs granted to the Reporting Person by the Issuer that began vesting on October 15, 2025 and that vest (and settle for underlying ordinary shares) in their entirety on December 30, 2026.
F9The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person by the Issuer that began vesting on October 15, 2025 and that vest (and settle for underlying ordinary shares) in their entirety on December 30, 2027.

Filing footnotes · 5

F1The ordinary shares reported in this row consist of shares underlying restricted share units ("RSUs") granted by the Issuer to the Reporting Person that began vesting (and settling for underlying ordinary shares) on July 15, 2023. The 30,820 RSUs originally granted vest in accordance with the following schedule: 33.33% of those RSUs vested upon the one-year anniversary of the vesting commencement date, and the remainder of those RSUs vest equally on a quarterly basis over the following eight quarters (8.3325% per quarter) such that all such 30,820 RSUs (reduced by any RSUs for which underlying shares have been sold) will be vested by the three-year anniversary of the vesting commencement date (July 15, 2026).
F2There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.
F3The ordinary shares reported in this row consist of shares underlying RSUs granted by the Issuer to the Reporting Person that began vesting (and settling for underlying ordinary shares) on July 15, 2024. The 35,480 RSUs originally granted vest in accordance with the following schedule: 33.33% of the RSUs vested upon the one-year anniversary of the vesting commencement date and the remaining RSUs vest equally on a quarterly basis over the following ten quarters (6.66% per quarter) such that all such 35,480 RSUs (reduced by any RSUs for which underlying shares are sold) will be vested by December 31, 2027.
F4The ordinary shares reported in this row consist of shares underlying 25,000 RSUs granted by the Issuer to the Reporting Person that began vesting (and settling for underlying ordinary shares) on March 13, 2025 and that vest (and settle for underlying ordinary shares) in their entirety on December 31, 2026.
F5The stock options reported in this row granted by the Issuer to the Reporting Person began vesting (and becoming exercisable for underlying ordinary shares) on October 1, 2022, in accordance with the following schedule: 25% of the options vested upon the one-year anniversary of the vesting commencement date and the remaining options vest equally on a quarterly basis over the following twelve quarters (6.125% per quarter) such that all such options will be vested by the four-year anniversary of the vesting commencement date.

Filing footnotes · 5

F1The transaction reported in this row consists of a sale-to-cover on behalf of the Reporting Person to cover tax liability for vesting of restricted share units ("RSUs") that had been granted by the Issuer to the Reporting Person.
F2The ordinary shares reported in this row consist of shares underlying RSUs granted by the Issuer to the Reporting Person that began vesting on July 15, 2023 and that vest (and settle for underlying ordinary shares) in accordance with the following schedule: Of the 5,850 RSUs originally granted, 33.33% of those RSUs vested upon the one-year anniversary of the vesting commencement date and the remainder of those RSUs vest equally on a quarterly basis over the following eight quarters (8.3325% per quarter) such that all such 5,850 RSUs (reduced by any RSUs for which underlying shares are sold to cover tax liability) will be vested by the three-year anniversary of the vesting commencement date (July 15, 2026).
F3The ordinary shares reported in this row consist of shares underlying RSUs granted by the Issuer to the Reporting Person that began vesting on July 15, 2024 and that vest (and settle for underlying ordinary shares) in accordance with the following schedule: Of the 19,830 RSUs originally granted, 33.33% of those RSUs vested upon the one-year anniversary of the vesting commencement date and the remainder of those RSUs vest equally on a quarterly basis over the following eight quarters (8.3325% per quarter) such that all such 19,830 RSUs (reduced by any RSUs for which underlying shares are sold to cover tax liability) will be vested by the three-year anniversary of the vesting commencement date (July 15, 2027).
F4There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.
F5The ordinary shares reported in this row consist of shares underlying RSUs granted by the Issuer to the Reporting Person that began vesting on July 15, 2025 and that vest (and settle for underlying ordinary shares) in accordance with the following schedule: 33.33% of the RSUs vested upon the one-year anniversary of the vesting commencement date and the remaining RSUs vest equally on a quarterly basis over the following eight quarters (8.3325% per quarter) such that all such RSUs will be vested by the three-year anniversary of the vesting commencement date.

Filing footnotes · 6

F1The transaction reported in this row consists of a sale-to-cover on behalf of the Reporting Person to cover tax liability for vesting of restricted share units ("RSUs") that had been granted by the Issuer to the Reporting Person.
F2The ordinary shares reported in this row consist of shares underlying RSUs granted by the Issuer to the Reporting Person that began vesting (and settling for underlying ordinary shares) on July 15, 2023. The 30,820 RSUs originally granted vest in accordance with the following schedule: 33.33% of the RSUs vested upon the one-year anniversary of the vesting commencement date and the remaining RSUs vest equally on a quarterly basis over the following eight quarters (8.3325% per quarter) such that all such 30,820 RSUs (reduced by any RSUs for which underlying shares are sold to cover tax liability) will be vested by the three-year anniversary of the vesting commencement date (July 15, 2026).
F3The ordinary shares reported in this row consist of shares underlying RSUs granted by the Issuer to the Reporting Person that began vesting (and settling for underlying ordinary shares) on July 15, 2024. The 35,480 RSUs originally granted vest in accordance with the following schedule: 33.33% of the RSUs vested upon the one-year anniversary of the vesting commencement date and the remaining RSUs vest equally on a quarterly basis over the following ten quarters (6.66% per quarter) such that all such 35,480 RSUs (reduced by any RSUs for which underlying shares are sold to cover tax liability) will be vested by December 31, 2027.
F4There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.
F5The ordinary shares reported in this row consist of shares underlying RSUs granted by the Issuer to the Reporting Person that began vesting on March 13, 2025 and that vest (and settle for underlying ordinary shares) in their entirety on December 31, 2026.
F6The stock options reported in this row granted by the Issuer to the Reporting Person began vesting (and becoming exercisable for underlying ordinary shares) on October 1, 2022, in accordance with the following schedule: 25% of the options vested upon the one-year anniversary of the vesting commencement date and the remaining options vest equally on a quarterly basis over the following twelve quarters (6.125% per quarter) such that all such options will be vested by the four-year anniversary of the vesting commencement date.

Filing footnotes · 10

F1The transaction reported in this row consists of a sale-to-cover (to cover tax liability) on behalf of the Reporting Person of ordinary shares received upon vesting of restricted share units ("RSUs") that had been granted by the Issuer to the Reporting Person.
F10The ordinary shares reported in this row consist of shares underlying RSUs granted to the Reporting Person that were granted to, and began vesting for, the Reporting Person on April 1, 2026 and that vest and settle for underlying ordinary shares based on the following schedule: 33% of the subject RSUs will vest upon the one-year anniversary of the grant date (April 1, 2027), and the remainder of the RSUs will vest in eight equal installments at the conclusion of each of the following eight quarters (8.25% per quarter), such that the RSUs will be fully vested by the three-year anniversary of the vesting commencement date (April 1, 2029).
F2The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person by the Issuer that began vesting on October 15, 2025. The 7,000 RSUs originally granted vest (and settle for underlying ordinary shares) on an equal, quarterly basis over three calendar quarters (33.33% per quarter) such that all such 7,000 RSUs (reduced by any RSUs for which underlying shares are sold to cover tax liability) will be vested by July 15, 2026.
F3The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person by the Issuer that began vesting on October 15, 2025. The 21,500 RSUs originally granted vest (and settle for underlying ordinary shares) on an equal, quarterly basis over seven calendar quarters (approximately 14.286% per quarter) such that all such 21,500 RSUs (reduced by any RSUs for which underlying shares are sold to cover tax liability) will be vested by July 15, 2027.
F4There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.
F5The ordinary shares reported in this row consist of shares underlying RSUs granted to the Reporting Person by the Issuer that began vesting on March 13, 2025 and that vest (and settle for underlying ordinary shares) in their entirety on December 31, 2027.
F6The ordinary shares reported in this row consist of shares underlying RSUs granted to the Reporting Person by the Issuer that began vesting on March 13, 2025 and that vest (and settle for underlying ordinary shares) in their entirety on July 15, 2026.
F7The ordinary shares reported in this row consist of shares underlying RSUs granted to the Reporting Person by the Issuer that began vesting on July 1, 2025 and that vest (and settle for underlying ordinary shares) in accordance with the following schedule: 33.33% of the RSUs vest upon the one-year anniversary of the vesting commencement date, and the remaining RSUs vest equally on a quarterly basis over the following eight quarters (8.3325% per quarter) such that all such RSUs will be vested by the three-year anniversary of the vesting commencement date.
F8The ordinary shares reported in this row consist of shares underlying RSUs granted to the Reporting Person by the Issuer that began vesting on October 15, 2025 and that vest (and settle for underlying ordinary shares) in their entirety on December 30, 2026.
F9The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person by the Issuer that began vesting on October 15, 2025 and that vest (and settle for underlying ordinary shares) in their entirety on December 30, 2027.